Dr. Fazal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4815 Liberty Ave
Ste 322
Pittsburgh, PA 15224Phone+1 412-578-4484Fax+1 412-578-3536
Education & Training
Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2007 - 2010
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceResidency, Internal Medicine, 2003 - 2006
King Edward Medical UniversityClass of 2001
Certifications & Licensure
PA State Medical License 2007 - 2024
CT State Medical License 2006 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 29 citationsSuccessful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.Rubens Costa, Salman Fazal, Robert B. Kaplan, Joel A. Spero, Ricardo Lima Barros Costa
Clinical Rheumatology. 2013-03-01 - 173 citationsRuxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.Robert Zeiser, Nicola Polverelli, Ron Ram, Shahrukh K Hashmi, Ronjon Chakraverty
The New England Journal of Medicine. 2021-07-15 - 170 citationsRuxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): A multicenter, open-label phase 2 trialMadan Jagasia, Miguel-Angel Perales, Mark A. Schroeder, Haris Ali, Nirav N. Shah
Blood. 2020-05-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
